Literature DB >> 31057739

Novel carbohydrate modified berberine derivatives: synthesis and in vitro anti-diabetic investigation.

Liwen Han1, Wenlong Sheng1, Xiaobin Li1, Attila Sik2, Houwen Lin3, Kechun Liu1, Lizhen Wang1.   

Abstract

Berberine is a bioactive alkaloid used in Chinese medicine and has numerous positive effects on biological systems. This paper describes the facile and highly efficient synthesis of some carbohydrate modified berberine derivatives, and conjugation of the carbohydrate moiety with berberine was finished by "click" chemistry. The cytotoxicity and anti-diabetic measurements of all berberine derivatives were accomplished on HepG2 cell lines, and the results indicated that most of the derivatives exhibit higher anti-diabetic activity than berberine. The mannose modified berberine derivative has significantly lower cytotoxicity than berberine, and the induced IC50 value of this derivative is nearly 1.5 times that of berberine. Furthermore, this mannose modified berberine derivative exhibits high anti-diabetic activity at both high and low drug concentrations, thereby indicating its potential application for the development of novel anti-diabetic drugs.

Entities:  

Year:  2019        PMID: 31057739      PMCID: PMC6482409          DOI: 10.1039/c9md00036d

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  30 in total

1.  Synthesis and antihyperglycemic evaluation of various protoberberine derivatives.

Authors:  Xiaoli Bian; Langchong He; Guangde Yang
Journal:  Bioorg Med Chem Lett       Date:  2005-12-15       Impact factor: 2.823

Review 2.  Adipocyte differentiation from the inside out.

Authors:  Evan D Rosen; Ormond A MacDougald
Journal:  Nat Rev Mol Cell Biol       Date:  2006-12       Impact factor: 94.444

3.  Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.

Authors:  Guochao Liao; Zhifang Zhou; Zhongwu Guo
Journal:  Chem Commun (Camb)       Date:  2015-06-14       Impact factor: 6.222

4.  Metabolites identification of berberine in rats using ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.

Authors:  Kun Wang; Liwei Chai; Xinchi Feng; Zhongbo Liu; Hongxia Liu; Liqin Ding; Feng Qiu
Journal:  J Pharm Biomed Anal       Date:  2017-02-27       Impact factor: 3.935

Review 5.  Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.

Authors:  Jiarong Lan; Yanyun Zhao; Feixia Dong; Ziyou Yan; Wenjie Zheng; Jinping Fan; Guoli Sun
Journal:  J Ethnopharmacol       Date:  2014-12-10       Impact factor: 4.360

6.  Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action.

Authors:  Nigel Turner; Jing-Ya Li; Alison Gosby; Sabrina W C To; Zhe Cheng; Hiroyuki Miyoshi; Makoto M Taketo; Gregory J Cooney; Edward W Kraegen; David E James; Li-Hong Hu; Jia Li; Ji-Ming Ye
Journal:  Diabetes       Date:  2008-02-19       Impact factor: 9.461

7.  Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux.

Authors:  Yong-Qiang Shan; Gang Ren; Yan-Xiang Wang; Jing Pang; Zhi-Yun Zhao; Jing Yao; Xue-Fu You; Shu-Yi Si; Dan-Qing Song; Wei-Jia Kong; Jian-Dong Jiang
Journal:  Metabolism       Date:  2012-10-15       Impact factor: 8.694

8.  The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption.

Authors:  Guo-Yu Pan; Zhi-Jiang Huang; Guang-Ji Wang; J Paul Fawcett; Xiao-Dong Liu; Xiao-Chen Zhao; Jian-Guo Sun; Yuan-Yuan Xie
Journal:  Planta Med       Date:  2003-07       Impact factor: 3.352

Review 9.  Carbohydrate CuAAC click chemistry for therapy and diagnosis.

Authors:  Xiao-Peng He; Ya-Li Zeng; Yi Zang; Jia Li; Robert A Field; Guo-Rong Chen
Journal:  Carbohydr Res       Date:  2016-03-29       Impact factor: 2.104

10.  Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.

Authors:  Xuan Xia; Jinhua Yan; Yunfeng Shen; Kuanxiao Tang; Jun Yin; Yanhua Zhang; Dongjie Yang; Hua Liang; Jianping Ye; Jianping Weng
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

View more
  4 in total

1.  Pyridine Derivative of the Natural Alkaloid Berberine as Human Telomeric G4-DNA Binder: A Solution and Solid-State Study.

Authors:  Francesco Papi; Carla Bazzicalupi; Marta Ferraroni; Giulia Ciolli; Paolo Lombardi; Asma Yasmeen Khan; Gopinatha Suresh Kumar; Paola Gratteri
Journal:  ACS Med Chem Lett       Date:  2020-02-07       Impact factor: 4.345

Review 2.  The Quest to Enhance the Efficacy of Berberine for Type-2 Diabetes and Associated Diseases: Physicochemical Modification Approaches.

Authors:  Solomon Habtemariam
Journal:  Biomedicines       Date:  2020-04-18

Review 3.  Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases.

Authors:  Xiaopeng Ai; Peiling Yu; Lixia Peng; Liuling Luo; Jia Liu; Shengqian Li; Xianrong Lai; Fei Luan; Xianli Meng
Journal:  Front Pharmacol       Date:  2021-11-03       Impact factor: 5.810

Review 4.  CuAAC-ensembled 1,2,3-triazole-linked isosteres as pharmacophores in drug discovery: review.

Authors:  Alisha Rani; Gurjaspreet Singh; Akshpreet Singh; Ubair Maqbool; Gurpreet Kaur; Jandeep Singh
Journal:  RSC Adv       Date:  2020-02-04       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.